Copay Cards and Cancer Medicines

A copay card is money from the company that makes a drug, applied to your share of the cost at the pharmacy counter. The formal name is a manufacturer copayment coupon.

The federal government does not treat it as charity. The HHS Office of Inspector General has a blunter description. It calls these coupons remuneration offered to consumers, meant to induce the purchase of specific items. That framing drives every rule that follows.

Two things a copay card is not. It is not insurance, and it does not lower the drug's price. It shifts who pays part of your share.

If your drug coverage comes from Medicare, Medicaid, TRICARE, or another federal health care program, you generally cannot use a manufacturer copay card. This is not a company policy. It is federal law.

OIG explains the two statutes involved. The Anti-Kickback Statute bars knowingly and willfully offering, paying, or receiving remuneration. The point of the ban is to stop payments that induce or reward business billed to federal programs. A second law adds a civil monetary penalty. It applies to offers that sway which provider, practitioner, or supplier a beneficiary picks for federally funded care.

Manufacturers must take steps to keep coupons out of federal program purchases. OIG also warns that pharmacies accepting coupons for federal beneficiaries may face sanctions.

This is why the fine print on nearly every card says federal program beneficiaries are not eligible.

Here is the uncomfortable part. OIG reviewed the safeguards and found them leaky.

Every manufacturer prints the notice. Most also build claim edits into pharmacy systems to block processing for Part D drugs. OIG found that most of those edits may not block every coupon. It also found that Part D plans cannot spot coupons inside pharmacy claims at all. That makes detection nearly impossible.

Roughly 6% to 7% of seniors in surveys OIG cited reported using coupons.

So the card may go through. The rules still apply to you. If you are on Medicare and a card works at the register, that is a system failure, not permission.

If you have job-based or Marketplace coverage, you can generally use a copay card. Then a second question matters: does the card's payment count toward your deductible and your out-of-pocket maximum?

Federal rules leave that to the plan. The HHS Notice of Benefit and Payment Parameters for 2021 settled the question loosely. Money paid through any form of direct support from drug makers may be counted toward the annual limit on cost sharing. It is not required to be, so long as state law allows that. An earlier version was narrower. It applied only when a generic was available and medically appropriate. The 2021 notice removed that qualifier.

The practical result is stark. A card can cover thousands of dollars of your cost share, while your own out-of-pocket total barely moves. Then the card hits its annual maximum in the spring, and you face a deductible you thought you had already met.

Ask your plan one question, in writing: do manufacturer assistance payments count toward my deductible and my out-of-pocket maximum? State laws differ on this, and so do plans.

Medicare has its own cost protections, and they are strong on the back end.

For 2026, Medicare states the yearly out-of-pocket cap for Part D drugs is $2,100. The most a plan may charge as a deductible is $615, and some plans charge none.

Extra Help is the low-income subsidy for Part D. Medicare says three groups qualify for it automatically. They are people on Medicaid, on a Medicare Savings Program, or on Supplemental Security Income. People who get Extra Help also do not pay a late enrollment penalty.

The Medicare Prescription Payment Plan solves a timing problem, not a cost problem. Instead of paying the pharmacy, you get a monthly bill from your drug plan. Medicare's own description is direct: it does not save you money or lower your drug costs.

Details worth knowing before you opt in:

• The monthly amount uses one formula. Take the balance left plus new drug costs, then divide by the months left in the year.
• Payments tend to rise later in the year, because fewer months remain to spread across.
• It helps most when large drug costs land early in the year.
• Enrolling before September leaves more months to spread across.
• You can join at any point in the year by contacting your plan, and enrollment renews automatically.
• A missed payment brings a reminder. If it stays unpaid past the deadline, you are removed from the program, and the balance is still owed.
• You never pay interest or fees, even on a late payment.

NCI's guidance on cancer costs names specific places to ask.

Inside the hospital: the billing office, a financial counselor, a social worker, or a case manager. If your coverage is through work, your human resources department and your insurer's benefits coordinator can confirm plan details.

Outside it, NCI names CancerCare, the Cancer Financial Assistance Coalition, the HealthWell Foundation, the Leukemia and Lymphoma Society, and Triage Cancer. For medicine costs specifically, NCI lists the Medicine Assistance Tool, NeedyMeds, RxAssist, Rx Outreach, and GoodRx. NCI's Cancer Information Service is 1-800-4-CANCER.

For Medicare patients, independent charitable foundations are the key category. Unlike a manufacturer card, a truly independent fund may be able to help federal beneficiaries. Funds are usually disease-specific and often run out, so timing matters.

1. Write down which coverage pays for the drug: commercial, Medicare Part B, Medicare Part D, or Medicaid.
2. If it is any federal program, skip manufacturer copay cards. Go to independent foundations instead. Also ask about the maker's own patient assistance program, which is a separate thing from a copay card.
3. If it is commercial, apply for the card. Then ask the plan in writing whether the card counts toward your deductible and out-of-pocket maximum.
4. Ask what the card's annual maximum is and what date it resets.
5. On Medicare, compare your expected costs against the $2,100 cap, and decide about the payment plan before September.
6. Ask the infusion or specialty pharmacy which foundations currently have open funds for your diagnosis.

• https://oig.hhs.gov/documents/special-advisory-bulletins/878/SAB_Copayment_Coupons.pdf
• https://oig.hhs.gov/reports/all/2014/manufacturer-safeguards-may-not-prevent-copayment-coupon-use-for-part-d-drugs/
• https://www.federalregister.gov/documents/2020/05/14/2020-10045/patient-protection-and-affordable-care-act-hhs-notice-of-benefit-and-payment-parameters-for-2021
• https://www.medicare.gov/health-drug-plans/part-d/basics/costs
• https://www.medicare.gov/publications/12211-whats-the-medicare-prescription-payment-plan.pdf
• https://www.cancer.gov/about-cancer/managing-care/track-care-costs